Home > Insider Trading > West Pharmaceutical Services Inc

West Pharmaceutical Services Inc (WST)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Should You Sell Your Holdings in West Pharmaceutical Services (WST)?

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

December 10th, 2024 - Hedge Fund Investor Letters News

10 Worst Performing Healthcare Stocks in 2024

The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.

Keep Reading →

November 26th, 2024 - Hedge Funds News

UBS' Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors

With November 2024 having settled in and the US presidential election in its final stages, investors are also digesting the results of the latest earnings season.

Keep Reading →

November 13th, 2024 - News

West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance

Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

October 30th, 2024 - Hedge Fund Investor Letters News

West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.

Keep Reading →

October 25th, 2024 - News Transcripts

West Pharmaceuticals (WST) Fell Due to Industry Headwinds

Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

October 22nd, 2024 - Hedge Fund Investor Letters News

Should You Hold West Pharmaceutical Services (WST) for the Long Term?

Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

August 19th, 2024 - Hedge Fund Investor Letters News

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024West Pharmaceutical Services, Inc. misses on earnings expectations.

Keep Reading →

July 26th, 2024 - News Transcripts

Does West Pharmaceutical Services (WST) Have Attractive Growth Drivers?

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

July 17th, 2024 - Hedge Fund Investor Letters News